
Zepbound side effects: what the 2026 label says, by dose
25 to 29% of adults on Zepbound had nausea vs 8% on placebo. Zepbound side effects by dose, how long they last, cancer risk, women, and Zepbound vs Wegovy.
How GLP-1 medications work, what the trials show, what they cost, and how to find a provider. All of it is grounded in FDA labels and peer-reviewed research.
Showing: Side effectsAll posts

25 to 29% of adults on Zepbound had nausea vs 8% on placebo. Zepbound side effects by dose, how long they last, cancer risk, women, and Zepbound vs Wegovy.

44% of adults on Wegovy 2.4 mg had nausea in trials. Every side effect by dose, the 7.2 mg and pill data, how long each one lasts, and the warning signs.

The gut effects match women. Three do not: muscle loss, testosterone, and erections. One ED database signal is 1.47% vs 0.32%. STEP-1 lean mass fell 9.7%.

GLP-1 side effects like nausea peak in the first weeks of each dose and ease by weeks 6–8. The week-by-week timeline, surgery precautions, and when to call.

GLP-1 hair loss affects about 2.5% in trials (more with big weight loss) and mostly women. It is telogen effluvium from rapid loss — preventable and reversible.

Ozempic face is mostly rapid facial fat loss, about 7% of midface volume per 10 kg in 2025 Vanderbilt imaging. It is not on the label, and collagen damage is unproven. What helps.